PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%

17 hours ago · Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore loss in FY23, driven by a reduction …

CouponFollow Extension

15%
OFF

PharmEasy Halves Loss To Rs 2,533 Crore In FY24, Revenue Dips 15%

1 week from now

17 hours ago · Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore loss in FY23, driven by a reduction …

indiatimes.com

15%
OFF

PharmEasy’s Revenue Drops 15% YoY, Losses Down 51% In FY24

1 week from now

1 day ago · The company’s total expenses dropped by 19.2% to Rs 7,254.8 crore in FY24. Its losses dropped 51.4% YoY to Rs 2,533.5 crore in FY24. PharmEasy ‘s revenue from …

infomance.com

15%
OFF

Mamaearth Rejects Allegations; PharmEasy’s Financials

1 week from now

12 hours ago · PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%. Mumbai-based online pharmacy PharmEasy has reported a 15% on-year decline in its revenue for …

indiatimes.com

15%
OFF

PHARMEASY FINANCIAL RESULTS - The Economic Times

1 week from now

Jan 23, 2024 · PharmEasy halves FY24 loss to Rs 2,533 crore, revenue dips 15% to Rs 5,664 crore. Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs …

indiatimes.com

15%
OFF

PharmEasy Halves Loss To Rs 2,533 Crore In FY24, Revenue Dips 15%

1 week from now

1 day ago · PharmEasy has reported a 14.7% decline in its revenue for 2023-24 to Rs 5,664 crore from Rs 6,644 crore in FY23 while its net loss fell to Rs 2,533 crore from Rs 5,212 crore, the …

businesstelegraph.co.uk

15%
OFF

PharmEasy Halves Loss To Rs 2,533 Crore In FY24, Revenue Dips 15%

1 week from now

PharmEasy, the Mumbai-based online pharmacy, reported a 14.7% decline in revenue for FY2023-24, amounting to Rs 5,664 crore. However, its net loss decreased to Rs 2,533 crore …

medial.app

16%
OFF

PharmEasy’s FY23 Operating Revenue Up 16% To Rs 6,644 Crore; Net …

1 week from now

Jan 30, 2024 · API Holdings, which runs online pharmacy PharmEasy, widened its consolidated net loss by 30% to Rs 5,212 crore in the financial year ended March though operating revenue …

indiatimes.com

16%
OFF

Pharmeasy – Financial Information, Revenue, Profit/Loss, Expenses

1 week from now

Jan 29, 2024 · FY 2022-23 Profit/Loss-₹5211.73 Cr. ... Jan 30, 2024 PharmEasy’s scale crosses Rs 6,600 Cr in FY23; losses down 16% . Expand more. Financial Comparison . A detailed …

thekredible.com

$1.78
OFF

PharmEasy Stock Price, Funding, Valuation, Revenue & Financial …

1 week from now

Funding, Valuation & Revenue. 16 Fundings. PharmEasy has raised $1.785B over 16 rounds. PharmEasy's latest funding round was a Series G - II for $216M on April 29, 2024. …

cbinsights.com

FAQs about PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15% Coupon?

How did PharmEasy perform in FY23?

Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore loss in FY23, driven by a reduction in goodwill impairment charges to Rs 582 crore from Rs 2,826 crore in FY23. ...

How did PharmEasy perform in 2023-24?

Mumbai-based online pharmacy PharmEasy has reported a 15% on-year decline in its revenue for 2023-24 while its net loss halved. Revenue from lab tests and other services stood at Rs 652 crore. Context: This comes after PharmEasy underwent a major restructuring of its cap table, slashing its valuation by 90% from its 2021 peak of $5.6 billion. ...

How has PharmEasy revenue changed in FY22 & FY23?

Revenue and Variable Expenses of Pharmeasy in Fy22, Fy23 and Q1Fy24 a) The revenue has increased by 5% from INR 6381 Cr in Fy22 to INR 6702 Cr in Fy23. Revenue from sale of goods increased by 6.8% to INR 5983 Cr in Fiscal 2023 from INR 5600 Cr in Fiscal 2022. ...

How to improve profitability by PharmEasy in FY23?

1. Steps taken to improve Profitability by Pharmeasy in Fy23 a) Marketing and growth expenses are reduced as a % of revenue from 7.9% in FY’22 to 3.3% in FY’23, with Q4’23 at 0.6% of revenue. It means total reduction of INR ~504 Cr in Fy22 to INR ~201 Cr in FY23. ...

Why did PharmEasy close its Rs 3500 crore rights issue?

PharmEasy has recently closed its Rs 3,500 crore rights issue, which gave it the much-needed room to clear pending debt and continue growing its business. Ranjan Pai, the chief of Bengaluru-based Manipal Group, emerged as the largest shareholder in API Holdings, with at least 15% stake after the rights issue. ...

Is PharmEasy facing a debt-repayment burden?

However, PharmEasy, which is facing a debt-repayment burden, saw its finance costs surge to Rs 665 crore in FY23, a more than 2.5 times increase from Rs 258 crore in FY22. ...